Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants

Direct oral anticoagulants (DOACs) have emerged as primary therapeutic option for stroke prevention in patients with atrial fibrillation. However, patients may have ischaemic stroke despite DOAC therapy and there is uncertainty whether those patients can safely receive intravenous thrombolysis or me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Seiffge, David (VerfasserIn) , Meinel, Thomas Raphael (VerfasserIn) , Purrucker, Jan (VerfasserIn) , Kaesmacher, Johannes (VerfasserIn) , Fischer, Urs (VerfasserIn) , Wilson, Duncan (VerfasserIn) , Wu, Teddy Y. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 February 2021
In: Journal of neurology, neurosurgery, and psychiatry
Year: 2021, Jahrgang: 92, Heft: 5, Pages: 534-541
ISSN:1468-330X
DOI:10.1136/jnnp-2020-325456
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1136/jnnp-2020-325456
Verlag, lizenzpflichtig, Volltext: https://jnnp.bmj.com/content/92/5/534
Volltext
Verfasserangaben:David J. Seiffge, Thomas Meinel, Jan Christoph Purrucker, Johannes Kaesmacher, Urs Fischer, Duncan Wilson, Teddy Y. Wu

MARC

LEADER 00000caa a2200000 c 4500
001 1760213675
003 DE-627
005 20230428014336.0
007 cr uuu---uuuuu
008 210610s2021 xx |||||o 00| ||eng c
024 7 |a 10.1136/jnnp-2020-325456  |2 doi 
035 |a (DE-627)1760213675 
035 |a (DE-599)KXP1760213675 
035 |a (OCoLC)1341415549 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Seiffge, David  |e VerfasserIn  |0 (DE-588)1121251536  |0 (DE-627)87420349X  |0 (DE-576)480795924  |4 aut 
245 1 0 |a Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants  |c David J. Seiffge, Thomas Meinel, Jan Christoph Purrucker, Johannes Kaesmacher, Urs Fischer, Duncan Wilson, Teddy Y. Wu 
264 1 |c 4 February 2021 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.06.2021 
520 |a Direct oral anticoagulants (DOACs) have emerged as primary therapeutic option for stroke prevention in patients with atrial fibrillation. However, patients may have ischaemic stroke despite DOAC therapy and there is uncertainty whether those patients can safely receive intravenous thrombolysis or mechanical thrombectomy. In this review, we summarise and discuss current knowledge about different approaches to select patient. Time since last DOAC intake—as a surrogate for anticoagulant activity—is easy to use but limited by interindividual variability of drug pharmacokinetics and long cut-offs (>48 hours). Measuring anticoagulant activity using drug-specific coagulation assays showed promising safety results. Large proportion of patients at low anticoagulant activity seem to be potentially treatable but there remains uncertainty about exact safe cut-off values and limited assay availability. The use of specific reversal agents (ie, idarucizumab or andexanet alfa) prior to thrombolysis is a new emerging option with first data reporting safety but issues including health economics need to be elucidated. Mechanical thrombectomy appears to be safe without any specific selection criteria applied. In patients on DOAC therapy with large vessel occlusion, decision for intravenous thrombolysis should not delay thrombectomy (eg, direct thrombectomy or immediate transfer to a thrombectomy-capable centre recommended). Precision medicine using a tailored approach combining clinicoradiological information (ie, penumbra and vessel status), anticoagulant activity and use of specific reversal agents only if necessary seems a reasonable choice. 
650 4 |a cerebrovascular disease 
650 4 |a stroke 
700 1 |a Meinel, Thomas Raphael  |d 1988-  |e VerfasserIn  |0 (DE-588)1075735750  |0 (DE-627)833649132  |0 (DE-576)444598952  |4 aut 
700 1 |a Purrucker, Jan  |d 1982-  |e VerfasserIn  |0 (DE-588)142755281  |0 (DE-627)638930405  |0 (DE-576)333199219  |4 aut 
700 1 |a Kaesmacher, Johannes  |d 1988-  |e VerfasserIn  |0 (DE-588)1220442798  |0 (DE-627)1737352974  |4 aut 
700 1 |a Fischer, Urs  |e VerfasserIn  |0 (DE-588)1211125130  |0 (DE-627)1698978715  |4 aut 
700 1 |a Wilson, Duncan  |e VerfasserIn  |0 (DE-588)1200903978  |0 (DE-627)1683961528  |4 aut 
700 1 |a Wu, Teddy Y.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of neurology, neurosurgery, and psychiatry  |d London : BMJ Publishing Group, 1944  |g 92(2021), 5, Seite 534-541  |h Online-Ressource  |w (DE-627)271594691  |w (DE-600)1480429-3  |w (DE-576)078707617  |x 1468-330X  |7 nnas  |a Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants 
773 1 8 |g volume:92  |g year:2021  |g number:5  |g pages:534-541  |g extent:8  |a Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants 
856 4 0 |u https://doi.org/10.1136/jnnp-2020-325456  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://jnnp.bmj.com/content/92/5/534  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210610 
993 |a Article 
994 |a 2021 
998 |g 142755281  |a Purrucker, Jan  |m 142755281:Purrucker, Jan  |d 910000  |d 911100  |d 50000  |e 910000PP142755281  |e 911100PP142755281  |e 50000PP142755281  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 3 
999 |a KXP-PPN1760213675  |e 3936592527 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 10.06.2021"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1468-330X"],"zdb":["1480429-3"],"eki":["271594691"]},"pubHistory":["N.S. 7.1944,3 - 42.1979; 43.1980 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulantsJournal of neurology, neurosurgery, and psychiatry","corporate":[{"display":"British Medical Association","role":"isb","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"recId":"271594691","part":{"volume":"92","issue":"5","extent":"8","pages":"534-541","text":"92(2021), 5, Seite 534-541","year":"2021"},"origin":[{"dateIssuedKey":"1944","dateIssuedDisp":"1944-","publisherPlace":"London","publisher":"BMJ Publishing Group"}],"note":["Gesehen am 30.11.12","Beteil. Körp. früher: British Medical Association"],"titleAlt":[{"title":"JNNP online"},{"title":"Journal of neurology, neurosurgery & psychiatry"}],"title":[{"title_sort":"Journal of neurology, neurosurgery, and psychiatry","subtitle":"a peer review journal for health professionals and researchers in all areas of neurology","title":"Journal of neurology, neurosurgery, and psychiatry"}]}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"4 February 2021"}],"recId":"1760213675","id":{"doi":["10.1136/jnnp-2020-325456"],"eki":["1760213675"]},"language":["eng"],"physDesc":[{"extent":"8 S."}],"title":[{"title_sort":"Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants","title":"Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","family":"Seiffge","given":"David","display":"Seiffge, David"},{"given":"Thomas Raphael","display":"Meinel, Thomas Raphael","roleDisplay":"VerfasserIn","role":"aut","family":"Meinel"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Purrucker","display":"Purrucker, Jan","given":"Jan"},{"given":"Johannes","display":"Kaesmacher, Johannes","role":"aut","roleDisplay":"VerfasserIn","family":"Kaesmacher"},{"given":"Urs","display":"Fischer, Urs","roleDisplay":"VerfasserIn","role":"aut","family":"Fischer"},{"display":"Wilson, Duncan","given":"Duncan","roleDisplay":"VerfasserIn","role":"aut","family":"Wilson"},{"given":"Teddy Y.","display":"Wu, Teddy Y.","family":"Wu","roleDisplay":"VerfasserIn","role":"aut"}],"name":{"displayForm":["David J. Seiffge, Thomas Meinel, Jan Christoph Purrucker, Johannes Kaesmacher, Urs Fischer, Duncan Wilson, Teddy Y. Wu"]}} 
SRT |a SEIFFGEDAVRECANALISA4202